Dr. Priya Ramsaha

Dr. Priya Ramsaha is one of Mauritius's leading oncologists, practising at Clinique Darné in Port Louis — a prestigious private hospital in the Mauritian capital that is widely regarded as one of the finest clinical facilities in the Indian Ocean. With 17 years of specialist experience in medical oncology, Dr. Ramsaha brings UK and European-level cancer care training to a region where oncological expertise is scarce. Mauritius has seen a rising incidence of cancer mirroring the epidemiological transition experienced by other middle-income island nations, with breast cancer, colorectal cancer, haematological malignancies, and lung cancer among the most common diagnoses. Dr. Ramsaha provides the full range of medical oncology services including systemic chemotherapy, targeted molecular therapies, immunotherapy, and multidisciplinary tumour board coordination alongside surgical and radiation oncology colleagues. Her practice is particularly recognised for breast cancer — which she manages from initial diagnosis through adjuvant and advanced disease settings using current ESMO and NCCN guidelines — and for haematological cancers including lymphoma, leukaemia, and multiple myeloma. She is a Fellow of the Royal College of Physicians of Edinburgh and an active member of ESMO and ASCO, through which she maintains access to the latest advances in oncological treatment that she translates into clinical practice in Mauritius. She is also a compassionate palliative care practitioner, working closely with nursing and allied health teams to optimise quality of life for patients with advanced cancer.

Dr. Ramsaha completed her MBBS at the University of Mauritius and pursued postgraduate clinical training in the United Kingdom. She earned her MRCP (UK) through the Royal Colleges of Physicians and undertook specialist oncology training at the Royal Marsden Hospital in London — one of the world's foremost cancer centres — and at the Christie Hospital in Manchester, earning her MD (Medical Oncology). She was elected as a Fellow of the Royal College of Physicians of Edinburgh (FRCP Ed) in recognition of her specialist expertise. She has participated in ESMO clinical oncology training programmes and attended advanced workshops on immunotherapy and molecular targeted therapy at the American Society of Clinical Oncology annual meeting.

Dr. Ramsaha's medical oncology practice is comprehensive, covering solid tumours and haematological malignancies. In breast oncology, she manages all stages of breast cancer from early-stage adjuvant chemotherapy and endocrine therapy through to metastatic disease with CDK4/6 inhibitors, anti-HER2 therapies (trastuzumab, pertuzumab, T-DM1), and PARP inhibitors for BRCA-mutated breast cancer. In haematological oncology, she initiates and monitors chemotherapy regimens for lymphomas, manages chronic and acute leukaemias, and coordinates haematopoietic stem cell transplant referrals to partner hospitals in South Africa and India where bone marrow transplantation is available. She administers checkpoint inhibitor immunotherapy for lung, melanoma, and other indications, and provides comprehensive palliative chemotherapy for patients with advanced cancer seeking disease control and symptom management.

Dr. Ramsaha has published in the Annals of Oncology and the Journal of Clinical Oncology on breast cancer outcomes in island populations with mixed ethnic backgrounds, and on the epidemiology of haematological malignancies in Mauritius. She contributed to an ESMO-supported study on cancer treatment access in small island developing states and has presented at ESMO Congress and the ASCO Annual Meeting on the challenges and innovations in oncology practice in the Indian Ocean region. She chairs the Clinique Darné tumour board's breast cancer working group.

Dr. Ramsaha provides consultations in English, French, and Mauritius Creole and is the principal oncologist managing international cancer patients at Clinique Darné. The clinic attracts patients from Réunion, Mayotte, the Comoros, Seychelles, Madagascar, and mainland Africa who seek chemotherapy, immunotherapy, and cancer management in Mauritius's high-quality private hospital environment. Dr. Ramsaha provides detailed oncological assessment reports in English or French for patients seeking second opinions from overseas specialists or transferring care between countries, and coordinates treatment plans in partnership with international oncologists when patients divide their time between Mauritius and their home country. Telemedicine consultations for second opinions are available.

Dr. Ramsaha received the Mauritius Oncology Society's Distinguished Clinician Award for her contributions to advancing cancer care standards in Mauritius and for her teaching of junior oncology trainees. She was recognised by Clinique Darné as its most cited specialist in patient satisfaction surveys for multiple consecutive years, and was selected by ESMO as a faculty member for oncology educational programmes delivered to physicians in the Indian Ocean and East African region.